NP Thyroid 30

Product NDC: 68788-8290
Requested package NDC: 68788-8290-3
11-digit product format: 687888290
Labeler code: 68788
Product ID: 68788-8290_a43b4a7d-ef80-41c8-b6b5-a224d4da307c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LEVOTHYROXINE, LIOTHYRONINE
Dosage form: TABLET
Route: ORAL
Labeler: Preferred Pharmaceuticals Inc
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2022-11-28
Marketing end: 0000-00-00
Substance: LEVOTHYROXINE; LIOTHYRONINE
Active strength: 19 ug/1; ug/1
Pharmacologic classes: Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	68788-8290	68788-8290-3	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68788-8290-3	EA - Each	68788-8290	081bfb61-4a00-4117-88a0-27d3121169ad	1	2023-01-09
68788-8290-6	EA - Each	68788-8290	d7942c1c-a293-4d6a-b48f-ce5b57f86f66	1	2023-01-09
68788-8290-9	EA - Each	68788-8290	2065127e-79ae-4f85-b7b3-28ff1cb273ed	1	2023-01-09

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
Q51BO43MG4	LEVOTHYROXINE	51-48-9	LEVOTHYROXINE
06LU7C9H1V	LIOTHYRONINE	6893-02-3	LIOTHYRONINE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68788-8290-3	68788829003	30 TABLET in 1 BOTTLE (68788-8290-3)	30 tablet	2022-11-28	0000-00-00	No	No	Current

NP Thyroid 30

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

DailyMed Billing Units#

Related Records#

Related UNII Ingredients#

Packages#

Related DailyMed Labels#